NDC 0641-0367-21 - Dexamethasone Sodium Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-0367
- Requested NDC
- 0641-0367-21
- Package NDCs from labels
- 0641-0367-21, 0641-0367-25
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | REMEDYREPACK INC. | 2026-03-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - A-S Medication Solutions | A-S Medication Solutions | 2026-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. | 2026-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-23 | HUMAN PRESCRIPTION DRUG LABEL |
| ReadySharp Anesthetics plus Dexamethasone - Terrain Pharmaceuticals | Terrain Pharmaceuticals | 2017-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-0367-21 | Dexamethasone Sodium Phosphate | 1 mL in 1 VIAL | INJECTION | 1 | 21 | |
| 0641-0367-25 | Dexamethasone Sodium Phosphate | 25 in 1 CARTON | INJECTION | 25 | 21 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-0367-21 | ML - Milliliter | 0641-0367 | 0ac648a0-35ec-434c-b33d-1645e8a8cc74 | 1 | 2012-07-24 |
| 0641-0367-25 | ML - Milliliter | 0641-0367 | b7f2dd89-0a90-48e6-ad12-aef4345ecf38 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Cool n Heat Lidocaine | LIDOCAINE HCL 4% | Walgreens Co | 0681c6c5-5a8b-ea9e-e063-6394a90a83bc | 2023-12-27 | Warnings | V13007Z41A |
| Leader Eye Wash | PURIFIED WATER | Cardinal Health | 8d3ad11f-1945-f838-e053-2995a90a7aa5 | 2023-12-23 | Warnings | 059QF0KO0R |
| equate Maximum Strength Pain Relieving 4% Lidocaine with Lavender Essential Oil Topical analgesic | LIDOCAINE HYDROCHLORIDE | Wal-Mart Stores, Inc. | bf954949-a7b7-44ba-8565-f1d5c0a6c0d1 | 2023-12-21 | Warnings | V13007Z41A |
| Bactine Max Bandage | LIDOCAINE | WellSpring Pharmaceutical Corporation | 465dc46e-6435-4569-9516-f648d0fe0f09 | 2023-12-21 | Warnings | V13007Z41A |
| Sinus HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, THUJA OCCIDENTALIS | Energique, Inc. | 3cdddbe5-e3d2-4629-a045-868e18183f1d | 2023-12-19 | Warnings | 451W47IQ8X |
| Lidocaine Pain Relief Roll-On | LIDOCAINE 4% | Humco Holding Group, Inc. | a8be9e46-1616-40a9-e053-2a95a90ac3bc | 2023-12-15 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | c5d27da0-e495-4bb6-a7e1-8eaa6595eb71 | 2023-12-14 | Warnings, Adverse reactions | V13007Z41A |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 451W47IQ8X 1Q73Q2JULR |
| Altachlore Sodium Chloride Hypertonicity | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | dc0d94d8-4475-4956-8ded-bdb9496074e4 | 2023-12-09 | Warnings | 451W47IQ8X |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Lidozen Gel | LIDOCAINE HYDROCHLORIDE, MENTHOL | Proficient Rx LP | 7c300dec-cefd-4b79-a948-a917b7708a04 | 2023-12-01 | Warnings | V13007Z41A |
| terrasil Eczema and Psoriasis Severe Outbreak | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 4d7128fb-57f1-4d0d-a83a-daef40928ecd | 2023-11-30 | Warnings | 451W47IQ8X |
| terragen HG Formula Maximum Strength | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | e632c831-e25d-4d04-ba72-2327d25713b1 | 2023-11-30 | Warnings | 451W47IQ8X |
| Thera Plus Max Strength Lidocaine Pain Relief Liquid | LIDOCAINE HYDROCHLORIDE | Fourstar Group USA, Inc. | 0a228b06-0e1c-6c75-e063-6294a90a9a0e | 2023-11-30 | Warnings | V13007Z41A |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 420119ca-f2bf-40e3-9e40-00498724c228 | 2023-11-30 | Warnings | 451W47IQ8X |
| CVS Maximum Strength LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | CVS Pharmacy Inc. | e6aff579-affb-41bb-8e36-53ea484cb0c5 | 2023-11-26 | Warnings | LKG8494WBH V13007Z41A |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Endopar | GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, OOPHORINUM (SUIS), ORCHITINUM (BOVINE), PINEAL GLAND, THYROIDINUM, ARSENICUM ALBUM, BARYTA CARBONICA, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PULSATILLA (PRATENSIS) | Energique, Inc. | 06375c3e-cc05-4450-9117-1d3dc72636eb | 2023-11-21 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 0a353fe1-b779-3d1f-e063-6294a90ab21b | 2023-11-15 | Warnings, Adverse reactions | 1010033 V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.